• Commercial

The Top 15 Specialty Pharmacies of 2025: PBM-Affiliated Pharmacies Dominate While Health Systems and Independents Gain Ground

pharminent April 21, 2026

• Pipeline

Serif, Flagship’s latest biotech, aims to make a new kind of genetic medicine

pharminent April 21, 2026

• Regulatory

FDA kicks off review of Roche’s Gazyva for wider lupus use

pharminent April 21, 2026

• Regulatory

Pfizer and Astellas secure FDA priority review for Padcev MIBC combo therapy

pharminent April 21, 2026

• M&A / Deals

Eli Lilly doubles down on in vivo with $7bn Kelonia buyout

pharminent April 21, 2026

• M&A / Deals

Asahi Kasei acquires German company Aicuris

pharminent April 21, 2026

• Regulatory

Pfizer and Astellas secure FDA priority review for Padcev MIBC combo therapy

pharminent April 21, 2026

• Policy / Pricing

Italy leads the way on child genetic disease diagnosis

pharminent April 21, 2026

• M&A / Deals

Asahi Kasei acquires German company Aicuris

pharminent April 21, 2026

• Policy / Pricing

Trump executive order lifts psychedelics biotechs

pharminent April 21, 2026

• Policy / Pricing

RFK Jr. defends HHS tenure, 12% proposed budget cut

pharminent April 20, 2026

• M&A / Deals

Lilly boosts ‘in vivo’ cell therapy capabilities with Kelonia buyout

pharminent April 20, 2026

• Policy / Pricing

FDA Achieves Year 1 Goals in Reducing Animal Testing in Drug Development

pharminent April 20, 2026

• Other

221: An Interview With Dutch Neurologist Ewout Groen of SMA Europe

pharminent April 20, 2026

• Other

AACR 2026: Revolution’s next prospect, Merck’s reveal and a lung cancer battle

pharminent April 20, 2026

• Other

Boehringer Ingelheim launches AI centre in London

pharminent April 20, 2026

• M&A / Deals

Lilly adds gene delivery technology to CAR T in up to $7B Kelonia deal

pharminent April 20, 2026

• Clinical Data

Novo’s late-stage sickle cell win piles pressure on competitors

pharminent April 20, 2026

• Other

S16 Ep55: OncoBytes Adaptive Learning Pathways: Personalizing Treatment Plans to Optimize Adjuvant Therapy in Early-Stage HR+/HER2- Breast Cancer

pharminent April 20, 2026

• Market Access

Beyond GLP-1Rs: emerging targets poised to gain share of obesity market

pharminent April 20, 2026

• Policy / Pricing

FDA Policy Tracker 2026: Psychedelics get a boost

pharminent April 20, 2026

• Other

UK Knowledge Quarter welcomes Boehringer Ingelheim AI accelerator

pharminent April 20, 2026

• M&A / Deals

Update: Lilly makes $7bn bid for in vivo CAR-T firm Kelonia

pharminent April 20, 2026

• Commercial

The Omnichannel Gap: Building the CRM of the Future for Patient Services

pharminent April 20, 2026

• Clinical Data

AZ is three for three with COPD hope tozorakimab

pharminent April 20, 2026

• Policy / Pricing

Trump backs psychedelics for mental health in new executive order

pharminent April 20, 2026

• M&A / Deals

UCB to purchase Neurona and NRTX-1001 for $1.15bn

pharminent April 20, 2026

• Regulatory

MSD secures EC approval for Enflonsia to prevent infant RSV infection

pharminent April 20, 2026

• M&A / Deals

UCB to purchase Neurona and NRTX-1001 for $1.15bn

pharminent April 20, 2026

• M&A / Deals

UCB cuts $1.15bn deal to buy epilepsy biotech Neurona

pharminent April 20, 2026

• Manufacturing

Magazine: Digital twins become the new battleground for CDMOs

pharminent April 20, 2026

• Other

What actually drives speed in complex drug development programs

pharminent April 20, 2026

• Policy / Pricing

Trump signs order to hasten psychedelic medicine access

pharminent April 19, 2026

• M&A / Deals

Kailera makes history with record-breaking $625m IPO

pharminent April 17, 2026

• Commercial

Lilly’s obesity pill off to a strong start; OpenAI debuts new drug discovery tool

pharminent April 17, 2026

• Commercial

Lilly’s Foundayo reaches 1,390 patients in first week, trailing Novo’s oral Wegovy launch

pharminent April 17, 2026

• M&A / Deals

Obesity biotech Kailera’s record-breaking IPO

pharminent April 17, 2026

• Other

S16 Ep53: Live Tumor Board: Squamous Cell Carcinoma of the Head & Neck – Post-CRT Decisions in the Locally Advanced Setting

pharminent April 17, 2026

• M&A / Deals

UPDATE: Kailera breaks biotech IPO record with $625M debut

pharminent April 17, 2026

• Policy / Pricing

RFK Jr. defends Makary, claims pharma ‘owns’ Congress and media

pharminent April 17, 2026